MAPT and Alzheimer disease: Magnetic resonance imaging (MRI) has been widely used to non-invasively probe the tissue changes associated with cerebral tau pathology in patients with AD and FTD (Du et al., 2006; Boxer et al., 2020; Young et al., 2021).